8. Selected Balance Sheet Information Prepaid expenses and other current assets (in thousands) | | | | | | | | | June 30, | | December 31, | | | 2026 | | 2025 | Prepaid insurance | | $ | 233 | | $ | 350 | Prepaid consulting, subscriptions and other expenses | | | 217 | | | 213 | VAT receivable | | | 107 | | | 32 | Prepaid clinical research organizations | | | 63 | | | — | Stock sales receivable | | | — | | | 452 | Other receivable | | | 21 | | | — | Prepaid manufacturing expenses | | | 12 | | | 13 | | | | | | | | Total prepaid expenses and other current assets | | $ | 653 | | $ | 1,060 |
Stock sales receivable was from at-the-market stock sales that was not cash settled prior to the period end. 8. Selected Balance Sheet Information – (continued) Property and equipment, net (in thousands) | | | | | | | | | June 30, | | December 31, | | | 2026 | | 2025 | Computers and office equipment | | $ | 639 | | $ | 639 | Other property, plant and equipment | | | 431 | | | 444 | Leasehold improvements | | | 94 | | | 94 | Software | | | 11 | | | 11 | | | | 1,175 | | | 1,188 | Less: accumulated depreciation and amortization | | | (1,002) | | | (966) | | | | | | | | Total | | $ | 173 | | $ | 222 |
During the six months ended June 30, 2026 and the year ended December 31, 2025 the Company recognized depreciation expense of $48,000 and $108,000 respectively. Accrued expenses (in thousands) | | | | | | | | | June 30, | | December 31, | | | 2026 | | 2025 | Accrued milestones payments | | $ | 5,000 | | $ | 5,000 | Accrued clinical consulting services | | | 832 | | | 842 | Accrued manufacturing costs | | | 332 | | | 257 | Accrued vendor payments | | | 254 | | | 177 | | | | | | | | Total accrued expenses | | $ | 6,418 | | $ | 6,276 |
Accrued employee benefits (in thousands) | | | | | | | | | June 30, | | December 31, | | | 2026 | | 2025 | Accrued compensation expense | | $ | 208 | | $ | 153 | Accrued vacation expense | | | 82 | | | 43 | Accrued bonus expense | | | — | | | 247 | | | | | | | | Total | | $ | 290 | | $ | 443 |
|